- Home
- YHGJ vs CVM Comparison
YHGJ vs CVM Comparison
Compare YHGJ & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- CVM
- Stock Information
- Founded
- YHGJ 1975
- CVM 1983
- Country
- YHGJ United States
- CVM United States
- Employees
- YHGJ N/A
- CVM N/A
- Industry
- YHGJ Specialty Chemicals
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YHGJ Industrials
- CVM Health Care
- Exchange
- YHGJ Nasdaq
- CVM Nasdaq
- Market Cap
- YHGJ 21.7M
- CVM 18.1M
- IPO Year
- YHGJ 1997
- CVM 1987
- Fundamental
- Price
- YHGJ $0.70
- CVM $9.45
- Analyst Decision
- YHGJ
- CVM
- Analyst Count
- YHGJ 0
- CVM 0
- Target Price
- YHGJ N/A
- CVM N/A
- AVG Volume (30 Days)
- YHGJ 19.4K
- CVM 2.0M
- Earning Date
- YHGJ 09-25-2025
- CVM 08-14-2025
- Dividend Yield
- YHGJ N/A
- CVM N/A
- EPS Growth
- YHGJ N/A
- CVM N/A
- EPS
- YHGJ N/A
- CVM N/A
- Revenue
- YHGJ $17,861,000.00
- CVM N/A
- Revenue This Year
- YHGJ N/A
- CVM N/A
- Revenue Next Year
- YHGJ N/A
- CVM N/A
- P/E Ratio
- YHGJ N/A
- CVM N/A
- Revenue Growth
- YHGJ 1.21
- CVM N/A
- 52 Week Low
- YHGJ $0.43
- CVM $1.98
- 52 Week High
- YHGJ $1.27
- CVM $39.30
- Technical
- Relative Strength Index (RSI)
- YHGJ 43.13
- CVM 74.98
- Support Level
- YHGJ $0.68
- CVM $7.02
- Resistance Level
- YHGJ $1.02
- CVM $9.76
- Average True Range (ATR)
- YHGJ 0.06
- CVM 1.31
- MACD
- YHGJ -0.01
- CVM 0.45
- Stochastic Oscillator
- YHGJ 5.26
- CVM 86.62
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.